# PROOF OF CONCEPT AGREEMENT

This Proof of Concept Agreement is made on [date] between [provider legal name], a [entity and state] with an address at [address] ("Provider"), and [evaluator legal name], a [entity and state] with an address at [address] ("Evaluator").

## 1. Evaluation

Provider will make the pre-release technology, software, device or service described in Schedule A (the "Prototype") available to Evaluator solely for the limited technical and business evaluation stated there. The authorized sandbox, devices, network and accounts are the "Evaluation Environment." The period from [start date] through [end date] is the "Evaluation Period."

The parties will perform the test steps and responsibilities in Schedule A (the "Test Plan") and compare measured results against the stated "Success Criteria." Completion or satisfaction of a Success Criterion does not require either party to buy, sell, license or deploy a production product.

## 2. Access and Authorized Use

During the Evaluation Period, Provider grants Evaluator a nonexclusive, nontransferable, revocable right to use the Prototype in the Evaluation Environment for the Test Plan. Access is limited to Evaluator personnel listed in Schedule A who need it and are bound by duties consistent with this Agreement.

Evaluator will not use the Prototype in production, provide a service to a third party, exceed stated capacity, bypass an access control, introduce malicious code, or test security outside the methods, targets, times and source addresses expressly authorized in Schedule A. It will not reverse engineer or decompile the Prototype except to the extent a nonwaivable law permits. No implied license is granted.

Provider may suspend access reasonably necessary to protect security, law, systems or third-party rights and will promptly explain the basis. Evaluator will notify Provider immediately of a vulnerability, unauthorized access or material malfunction and will not publicly disclose a vulnerability before the coordinated-disclosure date in Schedule A or applicable law.

## 3. Provider Duties

Provider will deliver the Prototype, credentials and documentation identified in Schedule A; provide the stated onboarding and support; maintain the Evaluation Environment components it controls; and correct a reproducible defect only to the extent the Test Plan requires. Provider will inform Evaluator of known material limitations affecting safe testing.

Provider may update the Prototype if the update does not materially defeat the Test Plan. If it does, the parties will adjust the Evaluation Period or Success Criteria in a signed change. Provider is not required to develop a feature not listed in Schedule A.

## 4. Evaluator Duties and Data

Evaluator will supply the personnel, equipment and connectivity assigned to it, follow documentation and reasonable security instructions, maintain credentials, and provide timely test observations. It is responsible for its configuration and for backing up its own systems.

Evaluator will use synthetic or de-identified data unless Schedule B expressly authorizes another defined dataset and allocates privacy, security and deletion duties. It will not submit protected health information, payment-card data, export-controlled data, children's data or production personal data without a separate signed agreement legally sufficient for that data.

Test inputs, logs, measurements and results identified in Schedule B are "Evaluation Data." Each party owns data it supplies. Provider may use Evaluation Data only to operate, secure and improve the Prototype and produce aggregated results that do not identify Evaluator, unless Schedule B grants broader rights.

## 5. Fees and Expenses

Evaluator will pay the fixed evaluation fee of $[amount] according to Schedule C. Unless Schedule C states otherwise, the fee is due [50%] at signing and [50%] on delivery of the Prototype and is not contingent on satisfying Success Criteria. Preapproved travel or third-party costs are reimbursable at cost with receipts.

Invoices are due within [30] days. Evaluator may withhold a disputed amount after prompt written detail but will pay the undisputed portion. Each party bears its own internal costs and taxes imposed on its income; transaction taxes are allocated in Schedule C.

## 6. Confidentiality

"Confidential Information" means nonpublic technical, business, security or financial information disclosed for this evaluation that is marked confidential or reasonably understood to be confidential. It includes the Prototype, source code, credentials, vulnerabilities, Test Plan, nonpublic results and each party's Evaluation Data.

The receiving party will use Confidential Information only for this Agreement, protect it with reasonable care, and disclose it only to personnel and advisers who need it and are bound by protective duties. Exclusions apply to information public without breach, previously known without duty, independently developed, or lawfully received from a third party. Legally compelled disclosure is permitted after notice where lawful and disclosure of only the required portion.

These duties continue for [three] years after disclosure; qualifying trade secrets remain protected while they qualify under Pennsylvania law.

## 7. Intellectual Property and Feedback

Provider owns the Prototype, documentation, updates and technology developed independently of Evaluator's Confidential Information. Evaluator owns its systems, supplied data and materials. No deliverable is a work made for hire and no ownership transfers except as expressly stated.

Evaluator may provide observations and suggestions ("Feedback"). Evaluator grants Provider a perpetual, worldwide, royalty-free right to use Feedback that does not include Evaluator Confidential Information or identify Evaluator. Provider may not publish Evaluator's name, endorsement or comparative result without written consent.

## 8. Prototype Risk and Liability

The Prototype is pre-release and may contain defects. Provider warrants only that it has authority to grant the evaluation right and will perform stated services with reasonable care. Except for nonwaivable warranties, the Prototype is provided for evaluation without warranties of merchantability, fitness, noninfringement or uninterrupted operation. Evaluator will not rely on it for safety-critical, financial, medical or legal decisions.

Each party is responsible for third-party claims caused by its infringement through materials it supplies, unlawful data use, negligence or willful misconduct. Except for payment, confidentiality breach, unauthorized system access, IP misuse, fraud and covered third-party claims, each party's aggregate direct liability is limited to [two] times fees paid or payable. Neither party is liable for consequential, punitive or lost-profit damages to the extent Pennsylvania law permits.

## 9. End of Evaluation

Either party may terminate for material breach not cured within [10] days after notice or immediately for unlawful activity, security risk or unauthorized production use. Either may terminate for convenience on [five] days' notice; Evaluator will pay for completed services and noncancelable approved costs.

At the end, Evaluator will stop access, return Provider devices, delete Prototype copies and credentials, and confirm deletion. Provider will return or delete Evaluator data as Schedule B states, retaining only legally required records and inaccessible routine backups subject to continuing protection. Accrued payment, confidentiality, IP, liability and general terms survive.

## 10. General Terms

Pennsylvania law governs without regard to conflicts rules. Courts in [county], Pennsylvania have exclusive jurisdiction. Neither party may assign this Agreement without consent except to a successor that assumes it and is not a direct competitor receiving Confidential Information. Notices must be in a retainable written form and delivered personally, by tracked courier or by email with confirmation.

This Agreement and schedules are the entire agreement for the proof of concept. Changes to scope, authorization, Success Criteria or data require a signed record. Invalid terms are severed to the minimum extent necessary. The parties agree to conduct this transaction electronically; counterparts and electronic signatures are effective.

PROVIDER

By: ____________________  Name/title: [name/title]  Date: [date]

EVALUATOR

By: ____________________  Name/title: [name/title]  Date: [date]

## SCHEDULE A — PROTOTYPE, TEST PLAN AND SUCCESS CRITERIA

Prototype, Evaluation Environment, authorized users and support: [details]

Test Plan, security authorization and Success Criteria: [details]

## SCHEDULE B — EVALUATION DATA AND SECURITY

Permitted datasets, ownership, safeguards, retention and deletion: [details]

## SCHEDULE C — FEES AND EXPENSES

Fee, milestones, reimbursable expenses and taxes: [details]


---
License: Licensed under CC BY 4.0. Attribution is required when you publish or redistribute this Template or an adapted version to the public. Attribution is not required merely because you use or adapt the Template for your own business or legal purposes, including preparing, negotiating, signing, or exchanging an agreement with a counterparty. License details.
License details: https://contract-templates.getfebruary.ai/license/